This report examines the early experience with the Medicare-Approved Drug Discount Card Program, prices offered by card sponsors, and potential savings for enrollees. The report presents information about approved discount card programs, including sponsors, enrollment fees, and drugs covered, as well as beneficiary education and outreach efforts by the Centers for Medicare & Medicaid Services. The pricing analysis shows that discount cards can deliver savings off of full retail drug prices, but also that savings for individual beneficiaries can vary significantly across card programs. In contrast to predictions that market forces would result in lower drugs prices, no notable price changes were observed after the program's initial start up period.

 Report and Executive Summary

The report was released at a July 28, 2004 briefing:

 Agenda

 Speaker Biographies

 Presentation Slides

 Webcast